Spain Ruminant Vaccines Market Size & Outlook, 2023-2030
Spain ruminant vaccines market, 2018-2030 (US$M)
Related Markets
Spain ruminant vaccines market highlights
- The Spain ruminant vaccines market generated a revenue of USD 153.7 million in 2023 and is expected to reach USD 251.3 million by 2030.
- The Spain market is expected to grow at a CAGR of 7.3% from 2024 to 2030.
- In terms of segment, modified/ attenuated live was the largest revenue generating vaccine type in 2023.
- Other Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
Ruminant vaccines market data book summary
| Market revenue in 2023 | USD 153.7 million |
| Market revenue in 2030 | USD 251.3 million |
| Growth rate | 7.3% (CAGR from 2023 to 2030) |
| Largest segment | Modified/ attenuated live |
| Fastest growing segment | Other Vaccines |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
| Key market players worldwide | Boehringer Ingelheim, Zoetis, Merck & Co Inc, Indian Immunologicals, Elanco Animal Health Inc, Virbac SA, Ceva Santé Animale |
Other key industry trends
- In terms of revenue, Spain accounted for 4.5% of the global ruminant vaccines market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany ruminant vaccines market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 15.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ruminant Vaccines Market Scope
Ruminant Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain ruminant vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ruminant vaccines market will help companies and investors design strategic landscapes.
Modified/ attenuated live was the largest segment with a revenue share of 51.4% in 2023. Horizon Databook has segmented the Spain ruminant vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
- Spain Ruminant Vaccines Vaccine Type Outlook (Revenue, USD Million, 2018-2030)
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
- Spain Ruminant Vaccines Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Injectable
- Others (e.g. Intranasal)
- Others (e.g. Oral, Intranasal)
- Others (e.g. Oral, Oculo-nasal etc.)
- Others (e.g. Immersion & Spray, Oral)
Reasons to subscribe to Spain ruminant vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain ruminant vaccines market databook
-
Our clientele includes a mix of ruminant vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain ruminant vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Spain ruminant vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain ruminant vaccines market size, by vaccine type, 2018-2030 (US$M)
Spain Ruminant Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
